Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

HBM HEALTHCARE INVESTMENTS AG

(HBMN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

EQS-Adhoc: Tata Digital to acquire majority stake in HBM portfolio company 1mg, India's leading digital healthcare platform

06/10/2021 | 11:48am EDT
EQS Group-Ad-hoc: HBM Healthcare Investments AG / Key word(s): Acquisition 
Tata Digital to acquire majority stake in HBM portfolio company 1mg, India's leading digital healthcare platform 
10-Jun-2021 / 17:45 CET/CEST 
Release of an ad hoc announcement pursuant to Art. 53 KR 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
HBM Healthcare Investments announced today, that Tata Digital, a fully-owned subsidiary of Tata Sons Private Limited, 
to acquire a majority stake of its privately held portfolio company 1mg. 
HBM Healthcare Investment was one of the early backers of 1mg and invested in various financing rounds a total of CHF 
17 million since May 2016. As part of the transaction with Tata Digital, which comprises a purchase of primary and 
secondary shares by Tata Digital, HBM Healthcare Investments to sell about one quarter of its shareholding and will 
continue to own a stake of about four percent in 1mg. 
Founded in 2015, 1mg is a leading player in the eHealth space and enables easy & affordable access to a wide range of 
products like medicines, health & wellness products, diagnostics services & tele-consultation to customers. The company 
operates three state of the art diagnostics labs, has a supply chain covering over 20,000 pincodes across the country 
and through its subsidiaries is also engaged in the business of B2B distribution of medicines & other healthcare 
products. 
Contact 
For further information, please contact Dr Andreas Wicki on +41 41 710 75 77, or at andreas.wicki@hbmhealthcare.com. 
About HBM Healthcare Investments 
HBM Healthcare Investments invests in the healthcare sector. The Company holds and manages an international portfolio 
of promising companies in the human medicine, biotechnology, medical technology and diagnostics sectors and related 
areas. Many of these companies have their lead products already available on the market or at an advanced stage of 
development. The portfolio companies are closely tracked and actively guided in their strategic direction. This is what 
makes HBM Healthcare Investments an interesting alternative to investments in big pharma and biotechnology companies. 
HBM Healthcare Investments has an international shareholder base and is listed on SIX Swiss Exchange (ticker: HBMN). 
Disclaimer 
The publication is for information purposes only and does not constitute an offer to sell or a solicitation to buy or 
subscribe for securities. This news release does not constitute a prospectus within the meaning of Art. 35ff FinSA, or 
securities prospectus in the sense of the German securities prospectus law. This news release and the information 
contained therein is not intended for distribution to the United States of America (USA) or within the USA and may not 
be distributed or forwarded to US persons (including legal persons) or to publications with a general distribution in 
the USA. This news release is not an offer or solicitation to buy securities in the United States. HBM Healthcare 
Investments AG's securities were not issued in accordance with the U.S. U.S. securities laws, and may not be sold, 
offered for sale, or delivered in the U.S. or to U.S. individuals without prior registration or without a registration 
exemption. Some information quoted was obtained from external sources HBM considers to be reliable. HBM cannot 
guarantee the adequacy, accuracy, timeliness or completeness of or be held responsible or liable for errors of fact 
regarding such data and information obtained from third parties, and this data may change with market conditions. 
=---------------------------------------------------------------------------------------------------------------------- 
End of ad hoc announcement 
=---------------------------------------------------------------------------------------------------------------------- 
Language:     English 
Company:      HBM Healthcare Investments AG 
              Bundesplatz 1 
              6300 Zug 
              Switzerland 
Phone:        +41438887171 
Fax:          +41438887172 
E-mail:       info@hbmhealthcare.com 
Internet:     https://www.hbmhealthcare.com 
ISIN:         CH0012627250 
Valor:        1262725 
Listed:       SIX Swiss Exchange 
EQS News ID:  1206801 
 
End of Announcement EQS Group News Service 
=------------ 

1206801 10-Jun-2021 CET/CEST

 
Image link: 
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1206801&application_name=news 
 

(END) Dow Jones Newswires

June 10, 2021 11:47 ET (15:47 GMT)

Stocks mentioned in the article
ChangeLast1st jan.
DJ INDUSTRIAL -0.21% 33874.24 Delayed Quote.10.91%
EHEALTH, INC. -0.16% 61.48 Delayed Quote.-12.63%
HBM HEALTHCARE INVESTMENTS AG 3.30% 359.5 Delayed Quote.14.10%
All news about HBM HEALTHCARE INVESTMENTS AG
06/21HBM HEALTHCARE INVESTMENTS  : Portfolio Company Ambrx Biopharma Raises $126 Mill..
MT
06/21HBM HEALTHCARE INVESTMENTS  : portfolio company Ambrx Biopharma raises USD 126 m..
EQ
06/18HBM HEALTHCARE INVESTMENTS  : Shareholders' Meeting of HBM Healthcare Investment..
EQ
06/18HUTCHMED CHINA  : Hutchison China MediTech Launches Hong Kong IPO of 104 Million..
MT
06/16HBM HEALTHCARE INVESTMENTS  : Upsizes Bond Offering to $110 Million on Strong De..
MT
06/16HBM HEALTHCARE INVESTMENTS  : has ended the subscription period for the bond ear..
EQ
06/16EQS-NEWS  : Key Figures 15.06.2021
DJ
06/16HBM HEALTHCARE INVESTMENTS  : Key Figures 15.06.2021
EQ
06/15HBM HEALTHCARE INVESTMENTS  : issues $67 Million Bond To Refinance Debt
MT
06/15EQS-ADHOC  : HBM Healthcare Investments Ltd -2-
DJ
More news
Financials
Sales 2022 - - -
Net income 2022 171 M 187 M 187 M
Net Debt 2022 45,0 M 49,0 M 49,0 M
P/E ratio 2022 14,1x
Yield 2022 3,53%
Capitalization 2 501 M 2 727 M 2 723 M
EV / Sales 2022 -
EV / Sales 2023 -
Nbr of Employees 700
Free-Float 83,0%
Chart HBM HEALTHCARE INVESTMENTS AG
Duration : Period :
HBM Healthcare Investments AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HBM HEALTHCARE INVESTMENTS AG
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 348,00 CHF
Average target price 355,00 CHF
Spread / Average Target 2,01%
EPS Revisions
Managers and Directors
NameTitle
Andreas Wicki Chief Executive Officer
Erwin Troxler Chief Financial Officer
Hans-Peter Hasler Chairman
Heinz Riesenhuber Vice Chairman
Eduard Enrico Holdener Director
Sector and Competitors
1st jan.Capitalization (M$)
HBM HEALTHCARE INVESTMENTS AG14.10%2 631
BLACKROCK, INC.19.85%131 899
BROOKFIELD ASSET MANAGEMENT INC.16.70%75 643
THE BLACKSTONE GROUP INC.51.84%65 318
UBS GROUP AG13.91%54 379
T. ROWE PRICE GROUP, INC.29.47%44 466